U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06961708) titled 'A Study of Fosmanogepix in Healthy Adult Chinese Subjects' on April 24.
Brief Summary: The purpose of this study is to investigate the pharmacokinetics and safety of the investigational drug fosmanogepix including its active moiety manogepix following a single dose and multiple doses (by intravenous infusion (IV) or orally) in healthy Chinese adults.
The study consists of 2 consecutive Parts (Part-1, single-dose part followed by Part-2, multiple-dose part) including a total of approximately 52 participants.
Part-1 duration will be up to 64 days including 4 visits at the clinical site and Part-2 duration will be up to 70 days includi...